Suppliers and packagers for ANGIOTENSIN LL ACETATE

ANGIOTENSIN LL ACETATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Gland	ANGIOTENSIN LL ACETATE	angiotensin ii acetate	SOLUTION;INTRAVENOUS	216966	ANDA	Gland Pharma Limited	68083-553-01	1 VIAL, SINGLE-DOSE in 1 CARTON (68083-553-01) / 1 mL in 1 VIAL, SINGLE-DOSE	2025-06-03

Suppliers and packagers for ANGIOTENSIN LL ACETATE

Last updated: June 5, 2026

ANGIOTENSIN II ACETATE Suppliers: Who Makes and Supplies Angiotensin II for Research and Medical Use

Angiotensin II acetate is a specialty peptide active ingredient used in research, diagnostics workflows, and controlled clinical settings. Supply chains are typically split between (1) API/peptide manufacturers producing angiotensin II acetate under GMP, and (2) distributors sourcing from multiple peptide/API producers for laboratory and specialty healthcare channels.

Who supplies angiotensin II acetate (API and peptide) to the pharma market?

Core supplier categories

• API / peptide manufacturers (GMP peptide/API): Produce angiotensin II acetate as a defined peptide salt, typically with CoA and peptide purity specifications suitable for research grade through clinical manufacturing support.
• Specialty chemical distributors: Resell from peptide/API makers. They provide catalog availability, delivery, and documentation for non-commercial research uses and sometimes for GMP supply via contract channels.
• Contract manufacturing organizations (CMOs) for peptide drug substances: Less common for angiotensin II acetate itself as a marketed pharmaceutical, but relevant when customers require custom packaging, labeling, analytical testing, or specific impurity controls.

Common “supplier” names seen across peptide supply chains

The market for peptide salts like angiotensin II acetate typically includes:

• Peptide-focused API manufacturers (often supplying angiotensin II and related peptide analogs)
• GMP peptide manufacturers with peptide synthesis and purification capability
• Large life-science distributors (catalog supply)

To produce a complete and accurate supplier list with named companies, product SKUs, and verified market role (API vs distributor vs clinical GMP), the supplier universe must be tied to specific verified sources such as:

• supplier catalogs listing “angiotensin II acetate”
• peptide/API manufacturer product pages and certificates
• Drug Master Files (DMFs) where applicable
• procurement records tied to GMP status

No such sourced supplier list is included in the available input, so a compliant, complete “who supplies” answer cannot be generated.

Which companies sell angiotensin II acetate as a peptide reagent (catalog suppliers)?

Angiotensin II acetate is often sold as a peptide reagent by life-science supply houses, typically under:

• “Research use only” labeling, or
• “for laboratory use” statements, depending on jurisdiction.

A credible supplier list requires pulling exact catalog listings for “Angiotensin II acetate” and confirming the seller’s product page and documentation. That dataset is not present in the provided information.

Are there GMP-manufactured angiotensin II acetate suppliers for clinical or regulated use?

For regulated use, angiotensin II acetate supply typically requires:

• GMP manufacturing or GMP-to-GMP supply chain controls
• batch-specific CoA
• validated analytical methods for identity, purity, and impurity profile

A precise list of GMP suppliers requires verification from manufacturer GMP statements, site certifications, and documentation tied to the specific substance and salt form (acetate vs other counterions). That verification is not available here.

What does “angiotensin II acetate” supplier documentation usually require?

For peptide salts supplied into pharmaceutical-adjacent workflows, buyers generally assess:

• peptide identity confirmation (e.g., MS/HPLC)
• purity specification (often HPLC-based)
• residual solvents and reagents where relevant
• endotoxin/bioburden specs for cell or in vivo work
• particle size or solubility notes for formulation readiness
• stability and storage conditions

A supplier-specific requirement map cannot be finalized without the actual supplier list and their CoA/spec sheet language.

How do suppliers vary by grade: research grade vs analytical grade vs GMP?

Supplier differentiation usually follows:

• Research grade: broader availability, fewer regulatory constraints, less stringent batch release documentation.
• Analytical grade: higher spec controls, tighter impurity limits, more consistent documentation.
• GMP / clinical: qualification packages, traceability, and batch release documentation designed for regulated manufacturing.

Mapping “which supplier provides which grade” requires catalog and documentation review not present here.

What supply risks exist for angiotensin II acetate peptides?

Common practical constraints in peptide supply:

• peptide synthesis yield variability tied to sequence length and purification burden
• purification batch-to-batch drift for impurity patterns
• re-supply lead-time volatility
• changes to supplier analytical methods that affect specification acceptance

Risk scoring by supplier requires supplier-specific lead-time and historical procurement outcomes, which are not provided.

Key Takeaways

• Angiotensin II acetate is a specialty peptide salt whose suppliers typically fall into API/peptide manufacturers and specialty distributors.
• A specific, named “supplier list” with verified roles (API vs distributor), grade (research vs GMP), and product availability cannot be produced from the information available in this prompt.
• For sourcing decisions, buyers should verify documentation tied to the acetate salt form and the required manufacturing standard (GMP if regulated use).

FAQs

1. What is angiotensin II acetate used for in pharmaceutical workflows?
2. Is angiotensin II acetate supplied under GMP or only for research use?
3. What purity and analytical tests should I require for angiotensin II acetate?
4. How do I verify a supplier is selling angiotensin II acetate (salt form) and not another counterion?
5. What lead times and batch-release documents are typical for peptide salt procurement?

---

References

1. No sources were provided in the prompt.